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Abstract The pattern electroretinogram (PERG) is
a retinal response evoked by viewing a temporally
alternating pattern, usually a black and white
checkerboard or grating. The PERG is important in
clinical and research applications because it provides
information both about retinal ganglion cell function
and, because the stimulus is customarily viewed with
central ﬁxation, the function of the macula. The
PERG can therefore facilitate interpretation of an
abnormal pattern VEP by revealing the retinal
responses to a similar stimulus to that used for the
VEP. However, practitioners may have difﬁculty
choosing between the different techniques for record-
ing the PERG that have been described in the
literature. The International Society for Clinical
Electrophysiology of Vision published a standard
for clinical PERG recording in 2000 to assist
practitioners in obtaining good quality reliable
responses and to facilitate inter-laboratory commu-
nication and comparison. This document is the
scheduled revision of that standard.
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Introduction
The pattern electroretinogram (PERG) is a retinal
biopotential evoked when a temporally modulated
patterned stimulus (checkerboard or grating) of
constant mean luminance is viewed. The PERG is
most often evoked by alternating contrast-reversal of
a black and white square checkerboard pattern with
central ﬁxation. It may be altered in dysfunction
conﬁned to the macula or to the retinal ganglion cells,
which do not signiﬁcantly affect the a- and b-waves
of the conventional full-ﬁeld ERG, and thus the
PERG receives clinical and research attention in both
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cally, the PERG can be used in a patient with an
abnormal visual evoked potential to establish whether
a retinal (macular) disorder is present, and thus
differentiate between macular and optic nerve
dysfunction as a cause for the VEP abnormality. It
can also directly demonstrate retinal ganglion cell
dysfunction.
However, the PERG is a very small signal,
typically in the region of 2–8 lV across a normal
population, and PERG recording is technically more
demanding than standard ﬂash ERGs. The amplitude
values recorded will depend upon stimulus charac-
teristics and the electrodes being used. The record-
ings published in the literature vary considerably in
technique and technical quality; this document is
intended to guide new or existing users to the most
appropriate techniques for recording a standard
clinical PERG.
The International Society for Clinical Electro-
physiology of Vision (ISCEV) initially published
‘‘PERG Guidelines’’ [1], intended as a guide to
practice and to assist in interpretation of PERGs.
Those guidelines were subsequently revised to a
PERG standard [2] and the present document is the
scheduled revision of that standard. The standard
PERG represents a minimum protocol for recording a
PERG with straightforward technical procedures that
should allow reproducible responses to be recorded
under deﬁned conditions. As a minimum, it is
intended that the standard method and responses be
widely used, but in addition to rather than to the
exclusion of other paradigms. Common additional
PERG techniques are also brieﬂy described in this
document, and individual laboratories are encouraged
to use additional stimuli and protocols tailored to
their own requirements.
The standard is based upon equipment and
analytic capabilities currently available in most
neurophysiological or ophthalmological electrodiag-
nostic clinics. This document addresses recording
conditions and technology speciﬁc to the PERG,
and presumes that the reader already has basic
understanding and skills in clinical electrophysiol-
ogy. Although much of the document will apply
equally to adults and children, the standard is not
necessarily appropriate to paediatric applications.
The standard will be reviewed by ISCEV in a
further four years.
Waveform nomenclature and measurement
The waveform of the PERG evoked by pattern-
reversal stimuli depends on the temporal frequency of
the stimulus. By convention, positivity is displayed
upward.
Transient PERG
The ISCEV standard PERG is a transient response i.e.
a response that is effectively complete before the next
contrast reversal. Transient recording allows separa-
tion of the PERG components. At low temporal
frequencies (<6 reversals per second (rev/s); equiv-
alent to <3 Hz) transient PERGs are obtained (Fig. 1).
The PERG waveform in normal subjects usually
consists of a small initial negative component with a
peak time of approximately 35 ms, N35, which is
followed at 45–60 ms by a much larger positive
component (P50). This positive component is fol-
lowed by a larger negative component at 90–100 ms
(N95).
For the transient PERG, amplitude measurements
are made between peaks and troughs: the P50
amplitude is measured from the trough of N35 to
the peak of P50. In some patients the N35 is poorly
deﬁned; in these cases N35 is replaced by the average
baseline between time zero and the onset of P50. The
N95 amplitude is measured from the peak of P50 to
the trough of N95. It should be recognised that
measured in this way, N95 amplitude includes the
P50 amplitude and P50 that of N35. It can be argued
that baseline to peak measurements may be more
meaningful. However, the P50 and N95 components
may not be independent. At the time of writing there
are no peer-reviewed data attempting to resolve these
Fig. 1 A normal PERG. The amplitude of P50 in a normal
subject is usually between 2.0 and 4.0 lV
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using peak-to-peak measures, they remain the
standard measures for PERG amplitudes.
The times to peaks in the waveform (implicit time)
should be measured from the onset of the contrast-
reversal to the peak of the component concerned; it
should be noted that the highest absolute amplitude
point on a waveform will not always be appropriate
for the deﬁnition of the peak if there is contamination
from muscle activity or other artifacts. The peak
should be designated where it would appear on a
smoothed or idealised waveform (see Fig. 1). The
peak times or implicit times are often (erroneously)
referred to as latencies. Correctly, latency refers to
the delay prior to the onset of a response, not to the
maximum activity of a peak.
Basic technology
Standard equipment for visual stimulus generation,
ampliﬁcation of physiological signals, and the record-
ing and storing of electrophysiological data, is
required for PERG testing. Information about the
calibration of equipment and measurement of
the parameters speciﬁed in this standard appears in
the ISCEV Calibration Guidelines [3].
Electrodes
Recording electrodes
Clinical ERG electrodes that contact the cornea or
nearby bulbar conjunctiva should be used as the active
electrodes to record standard PERGs. Electrodes that
degrade image quality on the retina (this includes all
contact lens electrodes) must not be used. Thin
conductive ﬁbres and foils can usually be positioned
without topical anaesthesia. Electrode integrity should
be checked prior to insertion, to meet guidelines for
each electrode type. It is recommended not to measure
impedance in situ unless explicitly speciﬁed by the
particular equipment manufacturer. Electrodes should
becarefullypositionedtominimiseinstability(amajor
source of artifact or interference). Those who perform
the test should be aware of possible causes of artifact.
• Fibre electrodes are best positioned in relation to
the upper margin of the lower eyelid. Some place
the electrode in the lower conjunctival fornix
(under the lower eyelid); such a position may
reduce trial-to-trial variability but will also result
in a lower amplitude PERG. Optimum stability is
achieved by tethering the electrode at the nasal
canthus.
• Foil electrodes should be positioned directly
under the centre of the pupil so that there is
minimal or no movement of the electrode when
the patient blinks. This is best achieved by having
the foil curve over the lower eyelashes without
contacting them, and then tethering the lead to the
cheek. The junction of the electrode and lead
should form as straight a line as possible and the
junction should not touch the skin.
• Loop electrodes should be hooked into the lower
fornix. Loops should be folded so that the contact
windows on otherwise insulated wire are posi-
tioned on the bulbar conjunctiva, about 5 mm
underthelimbus.Loopelectrodesshouldnottouch
the cornea. To achieve this, the limbs of the loop
shoulddivergewidely(15–20mm)beforeentering
the fornix. The lead is then taped to the cheek.
The appropriate techniques for individual elec-
trode types are very important to achieve stable and
reproducible PERG recordings. Additional sources
should be consulted in relation to the speciﬁc
electrode used.
Surface (skin) active electrodes should not rou-
tinely be used for recording the standard PERG; a
surface electrode positioned on the lower eyelid will
record PERGs of lower amplitude than those
recorded from an electrode in contact with the eye.
Surface electrode recordings may however be useful
when a corneal electrode is contraindicated or in
paediatric practice. The use of a surface electrode to
record the PERG is a variation from the standard and
should be noted in the report.
Reference electrodes
Separate surface reference electrodes should be
placed on the skin near the ipsilateral outer canthus
of each eye. Mastoid, earlobe or forehead locations
may result in contamination of the PERG from
cortical potentials or the fellow eye. If monocular
PERG recording is performed, the electrode in the
occluded eye may be used as a reference.
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A separate surface electrode should be attached and
connected to the ampliﬁer ‘‘ground input’’; the
forehead would be a typical location, but other
locations are acceptable as the location of the ground
electrode should not affect the standard PERG.
Surface electrodes
The skin should be prepared with a suitable cleaning
agent, and a suitable conductive paste used to ensure
good electrical connection. The impedance between
the skin electrodes used for reference and ground,
measured on the subject, should be less than 5 kX.
Since the electrode in the eye will have very low
impedance, a low impedance of the reference elec-
trode is also important to obtain recordings as free as
possible from mains (line frequency) interference.
Electrode cleaning and sterilisation
Electrodes should be cleaned and sterilised according
to local health and safety regulations. The ISCEV
Standard for full-ﬁeld ﬂash ERGs describes the
appropriate care of ERG electrodes [4].
Stimulus parameters
This standard speciﬁes the protocol for basic clinical
PERG recording. Laboratories may choose to test
more conditions or parameters than are described
herein.
Field and check size
A black and white reversing checkerboard should be
used for the standard PERG. It is not necessary to use
a square stimulus ﬁeld, but the aspect ratio between
the width and the height of the stimulus ﬁeld should
not exceed 4:3. The mean of the width and the height
of the stimulus ﬁeld should be 158 (±38) with a check
size of 0.88 (±0.168).
Luminance
PERGs are difﬁcult to record with low stimulus
luminance, and a photopic luminance level for the
white areas of greater than 80 cd  m
2 is required.
The mean luminance of the stimulus screen must be
constant during checkerboard reversals (i.e. no
transient luminance change).
Contrast
The contrast between black and white squares should
be maximal (close to 100%) for the standard PERG
and not less than 80%. The contrast and luminance
used should be reported.
Frame rate
Raster-based CRTs are typically used to present the
pattern stimuli. The frame rate of the CRT is a
signiﬁcant stimulus parameter for PERGs, and a
frequency of 75 Hz or greater should be used.
Background illumination
The luminance of the background beyond the check-
erboard ﬁeld is not critical when using the standard
PERG technique providing dim or ordinary room
lighting is used; ambient lighting should be the same
for all recordings. Care should be taken to keep bright
lights out of the subjects’ direct view. Pupil diameter
should be recorded.
Reversal rate
The standard transient PERG should be obtained
using a reversal rate of 4 rev/s ± 0.8 rev/s (i.e.
2 Hz ± 0.4 Hz).
Calibration
All stimulus parameters including luminance and
contrast should be calibrated either locally or by the
manufacturer and regular recalibration is advised [3].
Recording equipment
Ampliﬁcation systems
AC-coupled ampliﬁers with a minimum input
impedance of 10 MX should be used. Ampliﬁcation
systems must be electrically isolated from the patient
according to the current safety standards for medical
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bandpass ampliﬁers should include the range from
1–100 Hz; analogue notch ﬁlters (that suppress
signals at the alternating current line frequency)
should not be used. Some users may encounter severe
electromagnetic interference from the stimulus
display that makes it difﬁcult to obtain satisfactory
recordings with these ﬁlter settings. Ideally, such
interference should be eliminated by shielding or
modifying the equipment; rearranging the electrode
leads may be of beneﬁt.
Averaging and signal analysis
Signal averaging is necessary because of the small
amplitude of the PERG. The analysis period (sweep
time) for the standard PERGs should be 150 ms or
greater. Some laboratories assess baseline stability by
displaying two successive responses on the same
trace.
Artefact rejection
Computerised artifact rejection is essential. The
limits for rejection should be set at no higher
than ± 50 lV, and preferably lower. The ampliﬁers
must return to baseline rapidly following artifactual
signals to avoid inadvertent storage of non-physio-
logical data.
Sampling rate
A minimum sampling rate of 1,000 Hz (1 ms per
point) is recommended. See the calibration standard
(3) for further information.
Data display systems
Display systems must have adequate resolution to
represent accurately the characteristics of this small
amplitude signal. Ideally the recording system pro-
vides simultaneous display of the input signal and the
accumulating average. In the absence of a simulta-
neous display, the system should allow a rapid
alternation between displaying the input signal and
displaying the current average so that the quality of
the input signal can be adequately monitored. Even
with a computerised artifact rejection system, it is
important that the input signal be continuously
monitored for baseline stability and the absence of
ampliﬁer blocking.
Clinical protocol
Preparation of the patient
Positioning
The patient should be as comfortable as possible with
their head in a stable position against a head-rest. A
chin rest is inappropriate and should not be used.
Pupils
The PERG should be recorded without dilatation of
the pupils, to preserve accommodation and thus
retinal image quality.
Fixation
A ﬁxation mark in the centre of the screen at a node
of the checkerboard is essential. If there are any
doubts about the quality of ﬁxation in an individual
patient, an effective method is to give the patient a
(laser) pointer and have them point at the middle of
the screen throughout. Excessive blinking during
recording should be discouraged, pauses may be
advantageous.
Refraction
Because of the nature of the stimulus, PERG
examination should be performed with optimal visual
acuity at the testing distance. Patients should wear the
appropriate optical correction for the test distance.
Monocular and binocular recording
Proper positioning of recording and reference elec-
trodes will permit either monocular or binocular
recording of the PERG. Binocular recording is recom-
mended for the standard PERG because it is generally
more stable, it reduces examination time and it allows
ﬁxation by the better eye in cases of asymmetric visual
loss. Monocular stimulation is required to record the
PERG and the VEP simultaneously.
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A minimum of 100 artefact-free sweeps should be
collected and averaged for a standard PERG. More
sweeps, perhaps as many as 300, will be needed when
the PERG is small or undetectable or in a ‘‘noisy’’
subject. At least two trials for each stimulus condition
should be obtained to conﬁrm reproducibility (i.e. at
least one replication). It may be beneﬁcial to
superimpose repeated PERG recordings to evaluate
quality and reproducibility.
PERG reporting
Reporting
It is recommended that all reports contain measure-
ments of P50 and N95 amplitude (see above), and
P50 peak time (the peak of N95 is often rather broad
precluding accurate peak time measurement of this
component). All reports should also contain the
stimulus parameters (luminance, contrast, and ﬁeld
size), and normal ranges for the laboratory concerned.
Pupil size should be noted. Whenever practical,
reporting of PERG results should include represen-
tative waveforms with appropriate amplitude and
time calibrations, marks for the N35, P50 and N95
components, and should show replications.
Normative data/reference ranges
At present there are no standard international
reference ranges for PERG measurements. Each
laboratory should establish normal values for its
own equipment and patient population. It should be
noted that there are PERG changes with age.
Additional tests
Large ﬁeld PERGs
For some applications, such as glaucoma assessment,
a larger ﬁeld, such as 308, may be more appropriate.
Further, some practitioners ﬁnd the improved signal-
to-noise ratio obtained with a larger ﬁeld may have
advantages; users may wish to consider recording a
large ﬁeld PERG in addition to the standard response.
Steady-state PERG
At higher temporal frequencies, i.e. above 10 rev/s
(5 Hz), the successive waveforms overlap and a
‘‘steady-state’’ PERG is evoked. There are situations
in which the steady-state PERG is useful and some
laboratories favour it for glaucoma studies. Since
little extra time is required, laboratories may wish to
consider recording it in addition to the transient
response.
For steady-state PERG, a reversal rate of
approximately 16 rev/s (8 Hz) is recommended. The
steady-state PERG waveform is roughly sinusoidal,
and interpretation of steady-state PERGs requires
measurement of amplitude and phase shift (relative to
the stimulus) of the second harmonic by Fourier
analysis. The presence of a signiﬁcant ﬁrst harmonic
indicates technical problems. For correct interpreta-
tion the analysis period must be an integer number of
stimulus cycles, preferably greater than 6. Steady-
state PERG recording without the capability for such
analysis is not recommended.
Reporting of steady-state PERGs should include
the amplitude and phase shift of the PERG at the
reversal rate (i.e. at the second harmonic of the
stimulus rate in Hz).
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